ClinicalTrials.gov record
A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients
ClinicalTrials.gov ID: NCT00240448
Public ClinicalTrials.gov record NCT00240448. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised, Double-blind, Double-dummy, Placebo-controlled, Forced-titration, Comparison of MICARDIS® HCT (Telmisartan 80 mg / Hydrochlorothiazide 25 mg) Versus DIOVAN® HCT (Valsartan 160 mg / Hydrochlorothiazide 25 mg) Using Seated Trough Cuff Blood Pressure in Patients With Stage 1 and Stage 2 Hypertension
Study identification
- NCT ID
- NCT00240448
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Enrollment
- 1,109 participants
Conditions and interventions
Conditions
Interventions
- placebo Drug
- telmisartan 80 mg/hydrochlorothiazide 25 mg Drug
- valsartan 160 mg/hydrochlorothiazide 25 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2003
- Primary completion
- May 31, 2004
- Completion
- Not listed
- Last update posted
- Nov 4, 2013
Started 2003
United States locations
- U.S. sites
- 100
- U.S. states
- 36
- U.S. cities
- 93
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Boehringer Ingelheim Investigational Site | Birmingham | Alabama | — | — |
| Boehringer Ingelheim Investigational Site | Huntsville | Alabama | — | — |
| Boehringer Ingelheim Investigational Site | Mobile | Alabama | — | — |
| Boehringer Ingelheim Investigational Site | Sctoosdale | Arizona | — | — |
| Boehringer Ingelheim Investigational Site | Tucson | Arizona | — | — |
| Boehringer Ingelheim Investigational Site | Bentonville | Arkansas | — | — |
| Boehringer Ingelheim Investigational Site | Carlisle | Arkansas | — | — |
| Boehringer Ingelheim Investigational Site | Hot Springs | Arkansas | — | — |
| Boehringer Ingelheim Investigational Site | Concord | California | — | — |
| Memorial Research Medical Clinic | Long Beach | California | — | — |
| Boehringer Ingelheim Investigational Site | Orange | California | — | — |
| Boehringer Ingelheim Investigational Site | Riverside | California | — | — |
| Clinical Trials Research | Roseville | California | — | — |
| Boehringer Ingelheim Investigational Site | Sacramento | California | — | — |
| Boehringer Ingelheim Investigational Site | San Leandro | California | — | — |
| Boehringer Ingelheim Investigational Site | Santa Ana | California | — | — |
| Boehringer Ingelheim Investigational Site | Sepulveda | California | — | — |
| Boehringer Ingelheim Investigational Site | Spring Valley | California | — | — |
| Boehringer Ingelheim Investigational Site | Torrance | California | — | — |
| Boehringer Ingelheim Investigational Site | Boulder | Colorado | — | — |
| Boehringer Ingelheim Investigational Site | Bridgeport | Connecticut | — | — |
| Boehringer Ingelheim Investigational Site | Farmington | Connecticut | — | — |
| Clinical Research Consultants, Inc. | Trumbull | Connecticut | — | — |
| Boehringer Ingelheim Investigational Site | Waterbury | Connecticut | — | — |
| Boehringer Ingelheim Investigational Site | Newark | Delaware | — | — |
| Boehringer Ingelheim Investigational Site | Coral Gables | Florida | — | — |
| Boehringer Ingelheim Investigational Site | Fort Lauderdale | Florida | — | — |
| Boehringer Ingelheim Investigational Site | Fort Myers | Florida | — | — |
| Boehringer Ingelheim Investigational Site | Holiday | Florida | — | — |
| Boehringer Ingelheim Investigational Site | Hollywood | Florida | — | — |
| Christopher Chappel, MD | Kissimmee | Florida | — | — |
| Boehringer Ingelheim Investigational Site | Largo | Florida | — | — |
| Orlando Clinical Research Center | Orlando | Florida | — | — |
| Boehringer Ingelheim Investigational Site | Palm Harbor | Florida | — | — |
| Boehringer Ingelheim Investigational Site | Panama City | Florida | — | — |
| Attention: Larry I. Gilderman, D.O. | Pembroke Pines | Florida | — | — |
| Boehringer Ingelheim Investigational Site | Pembroke Pines | Florida | — | — |
| Boehringer Ingelheim Investigational Site | Atlanta | Georgia | — | — |
| Grady Memorial Hospital | Atlanta | Georgia | — | — |
| Boehringer Ingelheim Investigational Site | Conyers | Georgia | — | — |
| Treasure Valley Cardiology | Boise | Idaho | — | — |
| Boehringer Ingelheim Investigational Site | Chicago | Illinois | — | — |
| Cedar-Crosse Research Center | Chicago | Illinois | — | — |
| Herron Medical Center, Ltd. | Chicago | Illinois | — | — |
| Boehringer Ingelheim Investigational Site | Orland Park | Illinois | — | — |
| N Touch Research | Peoria | Illinois | — | — |
| Midwest Institute for Clinical Research Inc. | Indianapolis | Indiana | — | — |
| Boehringer Ingelheim Investigational Site | Waterloo | Iowa | — | — |
| Boehringer Ingelheim Investigational Site | Shawnee | Kansas | — | — |
| Boehringer Ingelheim Investigational Site | Wichita | Kansas | — | — |
| Boehringer Ingelheim Investigational Site | Louisville | Kentucky | — | — |
| Attn:William Smith | New Orleans | Louisiana | — | — |
| Boehringer Ingelheim Investigational Site | Baltimore | Maryland | — | — |
| Boehringer Ingelheim Investigational Site | Brookline | Massachusetts | — | — |
| Waltham Hospital | Waltham | Massachusetts | — | — |
| Boehringer Ingelheim Investigational Site | Troy | Michigan | — | — |
| Boehringer Ingelheim Investigational Site | Brooklyn Center | Minnesota | — | — |
| Radiant Research | Edina | Minnesota | — | — |
| Boehringer Ingelheim Investigational Site | Jackson | Mississippi | — | — |
| Boehringer Ingelheim Investigational Site | Kansas City | Missouri | — | — |
| Department of Medicine | Camden | New Jersey | — | — |
| Boehringer Ingelheim Investigational Site | Cherry Hill | New Jersey | — | — |
| Boehringer Ingelheim Investigational Site | Kingston | New York | — | — |
| Northport VAMC - Medical Service (111) | Northport | New York | — | — |
| Boehringer Ingelheim Investigational Site | Rochester | New York | — | — |
| Boehringer Ingelheim Investigational Site | Scarsdale | New York | — | — |
| Boehringer Ingelheim Investigational Site | The Bronx | New York | — | — |
| Boehringer Ingelheim Investigational Site | Burlington | North Carolina | — | — |
| Boehringer Ingelheim Investigational Site | Cary | North Carolina | — | — |
| Boehringer Ingelheim Investigational Site | Durham | North Carolina | — | — |
| Boehringer Ingelheim Investigational Site | Raleigh | North Carolina | — | — |
| Boehringer Ingelheim Investigational Site | Stateville | North Carolina | — | — |
| Boehringer Ingelheim Investigational Site | Winston-Salem | North Carolina | — | — |
| Boehringer Ingelheim Investigational Site | Cincinnati | Ohio | — | — |
| Radiant Reseach | Cincinnati | Ohio | — | — |
| Boehringer Ingelheim Investigational Site | Columbus | Ohio | — | — |
| Ohio State University | Columbus | Ohio | — | — |
| Radiant Research | Columbus | Ohio | — | — |
| Boehringer Ingelheim Investigational Site | Mansfield | Ohio | — | — |
| Boehringer Ingelheim Investigational Site | Mogadore | Ohio | — | — |
| Boehringer Ingelheim Investigational Site | Oklahoma City | Oklahoma | — | — |
| Boehringer Ingelheim Investigational Site | Tulsa | Oklahoma | — | — |
| Bock Clinical Research | Collegeville | Pennsylvania | — | — |
| Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| Boehringer Ingelheim Investigational Site | Pottstown | Pennsylvania | — | — |
| Boehringer Ingelheim Investigational Site | East Providence | Rhode Island | — | — |
| Boehringer Ingelheim Investigational Site | Greer | South Carolina | — | — |
| Boehringer Ingelheim Investigational Site | Nashville | Tennessee | — | — |
| Boehringer Ingelheim Investigational Site | Austin | Texas | — | — |
| Boehringer Ingelheim Investigational Site | Carrollton | Texas | — | — |
| Boehringer Ingelheim Investigational Site | Dallas | Texas | — | — |
| Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| Boehringer Ingelheim Investigational Site | McKinney | Texas | — | — |
| Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| Boehringer Ingelheim Investigational Site | Salt Lake City | Utah | — | — |
| Clinical Research Center of N. VA | Falls Church | Virginia | — | — |
| Boehringer Ingelheim Investigational Site | Lacey | Washington | — | — |
| Boehringer Ingelheim Investigational Site | Lakewood | Washington | — | — |
| Boehringer Ingelheim Investigational Site | Madison | Wisconsin | — | — |
| Boehringer Ingelheim Investigational Site | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00240448, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 4, 2013 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00240448 live on ClinicalTrials.gov.